HomeTELO • NASDAQ
add
Telomir Pharmaceuticals Inc
Previous close
$1.36
Day range
$1.34 - $1.38
Year range
$1.12 - $7.08
Market cap
47.10M USD
Avg Volume
834.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.15M | -80.91% |
Net income | -1.10M | 81.60% |
Net profit margin | — | — |
Earnings per share | -0.03 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.33M | 778.14% |
Total assets | 7.40M | 610.39% |
Total liabilities | 422.81K | -29.52% |
Total equity | 6.98M | — |
Shares outstanding | 34.38M | — |
Price to book | 6.48 | — |
Return on assets | -69.64% | — |
Return on capital | -74.96% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.10M | 81.60% |
Cash from operations | -927.26K | 7.49% |
Cash from investing | — | — |
Cash from financing | 7.50M | 16,093.18% |
Net change in cash | 6.57M | 726.62% |
Free cash flow | -639.66K | 82.38% |
About
Founded
2021
Headquarters
Website
Employees
5
